AVITA Medical, Inc. (RCEL)

NASDAQ: RCEL · USD

$16.5

+0.44 (+2.7%)· Recorded snapshot

Market cap	510.8M
Revenue (ttm)	75.6M
Net income (ttm)	-43.1M
EPS (ttm)	-$1.44
Shares out	30.9M
Volume	429,146
Beta	1.99

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 75.6M
Net income (ttm): -43.1M
EPS (ttm): -$1.44
Market cap: 510.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-84.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All RCEL indicators

Market & fundamental data

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001762303
Company name	AVITA Medical, Inc.
Country	United States
Country code	US
CUSIP number	05380C102
Earnings date	2026-11-05
Earnings time	amc
Employees	226
Employees change	-34
Employees growth	-13.08%
Enterprise value	$548.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US05380C1027
Last 10-K release date	2026-02-12
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2020-06-30
Last stock split type	Reverse
Market cap	$510.8M
Market cap category	Small-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$16.52
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	RCEL
U.S. state	California
Website	https://avitamedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-8.7%
EV/Sales	7.26x
FCF / EV yield	-4.48%
FCF yield	-4.81%
Forward EV/Sales	5.45x
Forward P/S	5.08x
Industry forward P/E	19.74x
Industry P/E	39.16x
P/S ratio	6.77x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-46.56%
EBITDA margin	-43.32%
Gross margin	81.56%
Operating margin	-46.56%
Pretax margin	-56.94%
Profit margin	-56.96%
Profit per employee	$-190,628
Revenue per employee	$334,650
ROA	-41.56%
ROCE	168.2%
ROIC	-84.11%
SBC / revenue	9.57%
Tax / revenue	0.03%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	6
EPS growth years	1
Gross profit growth	-2.26%
Gross profit growth (Q)	18.85%
Gross profit growth 3Y	21.84%
Gross profit growth 5Y	21.51%
Net income growth quarters	2
Net income growth years	1
Revenue growth	1%
Revenue growth (Q)	17.83%
Revenue growth (QoQ)	12.73%
Revenue growth 10Y	58.7%
Revenue growth 3Y	22.79%
Revenue growth 5Y	20.94%
Revenue growth quarters	2
Revenue growth years	9

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-387,000
Depreciation and amortization	$2.5M
EBIT	$-35.2M
EBITDA	$-32.8M
EPS	$-1.44
FCF per share	$-0.80
Financing cash flow	$20.5M
Free cash flow	$-24.6M
Free cash flow minus SBC	$-31.9M
Gross profit	$61.7M
Income taxes	$21,000
Investing cash flow	$600,000
Net borrowing	$6.1M
Net cash flow	$-3.1M
Net income	$-43.1M
Operating cash flow minus SBC	$-31.5M
Operating income	$-35.2M
Revenue	$75.6M
Stock-based compensation	$7.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-13.31
Book value per share	$-0.90
Interest coverage	-4.45
Long-term assets	$19.4M
Long-term liabilities	$6.9M
Net cash (debt)	$-37.3M
Net cash / market cap	-7.3%
Piotroski F-Score	2
Property, plant and equipment	$10.3M
Shareholders' equity	$-27.8M
Tangible book value	$-33.1M
Tangible book value per share	$-1.07
Total assets	$47.8M
Total cash	$11.1M
Total debt	$48.5M
Total liabilities	$75.6M
WACC	14.98%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.43
Current assets	$28.4M
Current liabilities	$68.7M
Current ratio	0.41
Inventory turnover	2.18
Net working capital	$-4.8M
Quick ratio	0.31
Working capital	$-40.3M
Working capital turnover	-2.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-14.29%
Dividend yield	0%
Shareholder yield	-14.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	50.82%
10Y return CAGR	4.2%
10Y total return	50.82%
150-day SMA	$7.12
1D price change	2.71%
1M price change	39.49%
1M total return	39.49%
1W price change	8.01%
1W total return	8.01%
1Y price change	335.75%
1Y return CAGR	336.19%
1Y total return	335.75%
20-day SMA	$13.89
200-day SMA	$6.43
3M price change	247.68%
3M total return	247.68%
3Y price change	77.77%
3Y return CAGR	21.14%
3Y total return	77.77%
50-day SMA	$11.97
50-day SMA vs 200-day SMA	50over200
52-week high	$16.60
52-week high date	2026-10-28
52-week low	$3.22
52-week low date	2026-01-07
5Y price change	-2.28%
5Y return CAGR	-0.46%
5Y total return	-2.28%
6M price change	262.17%
6M total return	262.17%
All-time high	$55.35
All-time high date	2020-02-19
All-time low	$3.22
All-time low date	2026-01-07
Average true range (ATR)	$0.82
Average volume	417.3K
Beta (1Y)	2.35
Beta (2Y)	1.89
Beta (5Y)	1.99
Change from 52-week high	-0.99%
Change from 52-week low	412.89%
Change from all-time high	-70.16%
Change from all-time low	412.89%
Change from open	3.74%
Day's gap	-1%
Dollar volume	$7.1M
High price	$16.60
Low price	$15.81
Monthly RSI	69.8
Open price	$15.92
Position in 52-week range	89.24%
Premarket change	0.56%
Premarket close	$16.08
Premarket price	$16.17
Premarket volume	9.4K
Previous close	$16.08
Price vs 150-day SMA	132.05%
Price vs 20-day SMA	18.91%
Price vs 200-day SMA	157.04%
Price vs 50-day SMA	37.98%
Relative volume	1.04
RSI	79.63
Sharpe ratio	1.92
Sharpe ratio (3Y)	0.56
Sharpe ratio (5Y)	0.34
Sortino ratio	4.91
Sortino ratio (3Y)	1
Sortino ratio (5Y)	0.62
Volume	429.1K
Weekly RSI	83.92
YTD price change	378.7%
YTD total return	378.7%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30.5M
Float percentage	98.5%
Shares change (QoQ)	0.68%
Shares change (YoY)	14.29%
Shares held by insiders	1.5%
Shares held by institutions	16.4%
Shares outstanding	30.9M
Short % of shares	9.43%
Short ratio	9.9 days

Deeper analysis on RCEL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this RCEL report

Is a complete RCEL research report available?

No complete published report is available for AVITA Medical, Inc. (RCEL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AVITA Medical, Inc. (RCEL)

Price

Financial snapshot

Fair-value bridge

Latest news · RCEL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RCEL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on RCEL

Frequently asked questions